What are Some Examples of Liposomal Doxorubicin Products?
Several liposomal doxorubicin formulations have been approved for clinical use:
Doxil (USA) / Caelyx (Europe): The first FDA-approved liposomal doxorubicin, used to treat ovarian cancer, multiple myeloma, and Kaposi's sarcoma. Myocet: A non-pegylated liposomal formulation used in combination with cyclophosphamide for metastatic breast cancer.